[PLX] YoY Annual Result on 31-Dec-2014 [#FY]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
12-Mar-2015
Financial Year
2014
Quarter
31-Dec-2014 [#FY]
Profit Trend
YoY- -7.75%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Annual Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 19,242 9,199 4,364 15,160 11,513 34,424 8,386 14.83%
PBT -85,276 -29,176 -27,282 -29,943 -27,790 -11,618 2 -
Tax 7,805 10,854 -87,566 -2,944 0 0 43,306 -24.82%
NP -85,276 -29,365 58,037 -29,943 -27,790 -11,618 -36,529 15.16%
Tax Rate - - - - - - -2,165,300.00% -
Total Cost 104,518 38,564 -53,673 45,103 39,303 46,042 44,915 15.10%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -443.18 -319.22 1,329.90 -197.51 -241.38 -33.75 -435.60 0.28%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -6.51 -0.29 0.61 -0.32 -0.30 -0.13 -0.43 57.21%
EPS Diluted -6.51 -0.29 0.61 -0.32 -0.30 -0.13 -0.43 57.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.